Infertility Clinical Trial
Official title:
Effect of Vaginal Sildenafil Citrate on Endometrial Preparation and Outcome in Frozen Thawed Embryo Transfer Cycles
A total of 80 Patients who meet these conditions will enter the study and be divided into two
groups based on randomized tables.
To prepare the endometrium,
Group A : 40 women are given oral estradiol valerate tablets 2mg 6-8 hourly from the day 2-14
of the cycle to prepare the endometrium
Group B : 40 women are give sildenafil citrate 25mg vaginally every 6 hours (a half of 50 mg
tablet is crushed and dissolved in 2cc of distilled water and injected in to vagina) starting
from day 2-14 of the cycle, in addition to oral 2mg of estradiol valerat 6-8 hourly from the
day 2-14 of the menstrual cycle . Estrogen and progesterone (prontogest 400mg pessaries ) are
given 3 days prior to embryo transfer. Sildenafil is discontinued 48-72 hours prior to the
embryo transfe due sildenafil may have some detrimental effects on endometrium in the
implantation window
A total of 80 Patients who meet these conditions will enter the study and be divided into two
groups based on randomized tables.
To prepare the endometrium,
Group A : 40 women are given oral estradiol valerate tablets 2mg 6-8 hourly from the day 2-14
of the cycle to prepare the endometrium
Group B : 40 women are give sildenafil citrate 25mg vaginally every 6 hours (a half of 50 mg
tablet is crushed and dissolved in 2cc of distilled water and injected in to vagina) starting
from day 2-14 of the cycle, in addition to oral 2mg of estradiol valerat 6-8 hourly from the
day 2-14 of the menstrual cycle . Estrogen and progesterone (prontogest 400mg pessaries ) are
given 3 days prior to embryo transfer. Sildenafil is discontinued 48-72 hours prior to the
embryo transfe due sildenafil may have some detrimental effects on endometrium in the
implantation window.
For assessing endometrial vascularity (on day 14 of cycle), two dimension power Doppler
characteristics as normal quality of color, color gain-3.4, pulse repetition frequency of
600Hz and wall motion filter of 50Hz are applied in all examinations. By following
Applebaum's zones of vascularity for categorizing endometrial vasculaity: Zone 1
vascularity-When blood vessls reach the hypoechoic endometrio-myometria junction, Zone 2
vascularity when the vessels reach the outer hyperechoic line of en-dometrium, Zone 3
vascularity when it reach the intervening hypoechoic area, Zone 4 vascularity when the
vessels are seen reaching the central echogenic line .
After 5 days when the endometrial pattern is triple line pattern (trilaminar) and endometrial
thickness is more than 8mm,embryos will be transferred. All patients have a luteal phase
support by giving a daily doses of estradiol valerat 2mg oral daily and 100mg progesterone
(prontogest 100mg ampoule ) as an intramuscular which will be continued two weeks after the
em-bryos transfer. In case BHCG is tested and proved to be positive, estradiol valerat and
progesterone are continueed until the 11th week of pregnancy. Then, four weeks after the
embryo transfer, the number of gestational sacs are determined by vaginal ultrasound.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A |